Clinically-relevant ABC transporter for anti-cancer drug resistance

H Xiao, Y Zheng, L Ma, L Tian, Q Sun - Frontiers in pharmacology, 2021 - frontiersin.org
Multiple drug resistance (MDR), referring to the resistance of cancer cells to a broad
spectrum of structurally and mechanistically unrelated drugs across membranes, severely …

ATP-binding cassette efflux transporters and MDR in cancer

MS Pote, RN Gacche - Drug Discovery Today, 2023 - Elsevier
Highlights•The most common reason for the failure of the cancer treatment is the evolving
drug resistance.•The ABC transporters mainly P-gp, BCRP and MRP1 are responsible for …

The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade

RJ Kathawala, P Gupta, CR Ashby Jr, ZS Chen - Drug resistance updates, 2015 - Elsevier
ATP-binding cassette (ABC) transporters represent one of the largest and oldest families of
membrane proteins in all extant phyla from prokaryotes to humans, which couple the energy …

[HTML][HTML] Mechanisms of drug resistance in colon cancer and its therapeutic strategies

T Hu, Z Li, CY Gao, CH Cho - World journal of gastroenterology, 2016 - ncbi.nlm.nih.gov
Drug resistance develops in nearly all patients with colon cancer, leading to a decrease in
the therapeutic efficacies of anticancer agents. This review provides an up-to-date summary …

Targeting multidrug resistance-associated protein 1 (MRP1)-expressing cancers: Beyond pharmacological inhibition

KM Hanssen, M Haber, JI Fletcher - Drug Resistance Updates, 2021 - Elsevier
Resistance to chemotherapy remains one of the most significant obstacles to successful
cancer treatment. While inhibiting drug efflux mediated by ATP-binding cassette (ABC) …

Multidrug resistance proteins (MRPs) and cancer therapy

YK Zhang, YJ Wang, P Gupta, ZS Chen - The AAPS journal, 2015 - Springer
The ATP-binding cassette (ABC) transporters are members of a protein superfamily that are
known to translocate various substrates across membranes, including metabolic products …

[HTML][HTML] Folic acid (FA)-conjugated mesoporous silica nanoparticles combined with MRP-1 siRNA improves the suppressive effects of myricetin on non-small cell lung …

Y Song, B Zhou, X Du, Y Wang, J Zhang, Y Ai… - Biomedicine & …, 2020 - Elsevier
Non-small cell lung cancer (NSCLC) is a common diagnosed cancer disease worldwide and
its management remains a challenge. Synergistic cancer therapeutic strategy is interesting …

Tyrosine kinase inhibitors enhanced the efficacy of conventional chemotherapeutic agent in multidrug resistant cancer cells

S Wu, L Fu - Molecular cancer, 2018 - Springer
Multidrug resistance (MDR) triggered by ATP binding cassette (ABC) transporter such as
ABCB1, ABCC1, ABCG2 limited successful cancer chemotherapy. Unfortunately, no …

Role of multidrug resistance-associated proteins in cancer therapeutics: past, present, and future perspectives

A Elfadadny, HM El-Husseiny, A Abugomaa… - … Science and Pollution …, 2021 - Springer
Cancer, a major public health problem, is one of the world's top leading causes of death.
Common treatments for cancer include cytotoxic chemotherapy, surgery, targeted drugs …

Reversal effect of quercetin on multidrug resistance via FZD7/β-catenin pathway in hepatocellular carcinoma cells

Z Chen, C Huang, T Ma, L Jiang, L Tang, T Shi… - Phytomedicine, 2018 - Elsevier
Background Chemotherapy has been widely used to treat cancer, but the appearance of
multidrug resistance (MDR) is the biggest obstacle to successful chemotherapy. One of the …